As of Apr 24
| +0.07 / +0.61%|
The 5 analysts offering 12-month price forecasts for Cross Country Healthcare Inc have a median target of 13.50, with a high estimate of 15.00 and a low estimate of 13.00. The median estimate represents a +16.38% increase from the last price of 11.60.
The current consensus among 6 polled investment analysts is to Buy stock in Cross Country Healthcare Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.